Table 4 Comparison of documented performance and patient self-report according to clinic setting

Evaluation of quality of life (EU)

0/147 (0.0%)

27/140 (19.3%)

0/56 (0.0%)

15/52 (28.9%)

0/55 (0.0%)

18/55 (32.7%)

Assessment of cardiovascular risk factors by rheumatologist (US)

91/147** (61.9%)

14/56** (25.0%)

8/55** (14.5%)

Assessment of cardiovascular risk factors by family physician

50/139* (36.0%)

21/51* (41.2%)

31/54* (57.4%)

Assessment of cardiovascular risk factors by either rheumatologist or family physician

Assessment for drug toxicity (EU)

141/147**

(95.9%)

37/138

(26.8%)

43/56** (76.8%)

23/52

(44.2%)

44/54** (81.5%)

20/54 (37.0%)

Ophthalmologic review if on hydroxychloroquine as per guidelines (EU)

46/103** (44.7%)

69/103 (67.0%)

11/34** (32.4%)

24/31 (77.4%)

27/38** (71.1%)

33/38 (86.8%)

Ophthalmologic review if on glucocorticoids as per guidelines (EU)

34/67** (50.8%)

45/67 (67.2%)

5/22** (22.7%)

18/21 (85.7%)

16/23** (69.6%)

20/23 (86.9%)

Counselling when prescribed new medications (US)

118/139** (84.9%)

116/144 (80.6%)

14/48** (29.2%)

44/47 (93.6%)

26/44** (59.1%)

38/44 (86.4%)

Calcium and vitamin D supplementation if received prednisolone >7.5 mg for >3 months (US)

93/105 (88.6%)

94/104 (90.4%)

27/31 (87.1%)

29/29 (100%)

22/24 (91.7%)

22/24 (91.7%)

All patients should be vaccinated against influenza and pneumococcus (EU)

34/147** (23.1%)

27/139 (19.4%)

1/55** (1.8%)

16/50 (32.0%)

2/55** (3.6%)

8/54 (14.8%)

All patients should be vaccinated against influenza

–

92/147

(62.6%)

–

34/52

(65.4%)

–

36/55

(65.5%)

All patients should be vaccinated against pneumococcus

–

27/139

(19.4%)

–

16/50

(32.0%)

–

9/54

(16.7%)

Rheumatologist recommended vaccination?

–

82/136* (60.3%)

–

28/52* (53.9%)

–

20/55* (36.4%)

Influenza vaccination if on immunosuppressants (US)

64/96** (66.7%)

61/96 (63.5%)

5/46** (10.9%)

30/43 (69.8%)

2/36** (5.6%)

24/36 (66.7%)

Pneumococcal vaccination if on immunosuppressants (US)

21/96** (21.9%)

24/91 (26.4%)

1/46** (2.2%)

16/41 (39.0%)

1/34** (2.9%)

8/33 (24.2%)

Sun avoidance counselling ever (US)

27/147* (18.4%)

125/144 (86.8%)

5/56* (8.9%)

45/52 (86.5%)

2/55* (3.6%)

47/55 (85.5%)

Teratogenic medication risk and contraception counselling in reproductive age women (US)

42/64** (65.6%)

53/63** (84.1%)

4/20** (20.0%)

9/17** (52.9%)

6/14** (42.9%)

5/13** (38.5%)